Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000458409 | SCV000557192 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001696907 | SCV000714712 | likely benign | not provided | 2019-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617827 | SCV000737418 | likely benign | Cardiovascular phenotype | 2017-03-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001696907 | SCV001472533 | benign | not provided | 2021-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253449 | SCV002525058 | benign | Cardiac arrhythmia, ankyrin-B-related | 2021-12-05 | criteria provided, single submitter | clinical testing |